MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Dec. 19, 2008--PhotoMedex, Inc. (Nasdaq:PHMD) announced that its next Annual
Stockholders' Meeting will be held on January 26, 2009, at the offices
of Morgan, Lewis & Bockius LLP, 1701 Market Street, Philadelphia, PA
19103. The meeting will begin at 10:30 AM.
Information on the Stockholders' Meeting, including routine proposals
and proposals related to the transaction with Photo Therapeutics, that
will b...
Improved Formulation Targets Dark Circles
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Nov. 10, 2008--PhotoMedex,
Inc. (Nasdaq:PHMD) announced today that Procyte, a PhotoMedex company,
has launched its improved Neova(R) Eye Therapy to now tackle the
biggest eye area challenge. Neova(R) Eye Therapy now contains
Haloxyl(TM), a revolutionary lightening agent clinically proven to
reduce the appearance of dark circles around the eyes. Still
chock-full of a proprietary blend of botanical in...
MONTGOMERYVILLE, Pa., Nov 04, 2008 (BUSINESS WIRE) -- PhotoMedex, Inc. (NASDAQ:PHMD), will participate in the Rodman & Renshaw
10th Annual Healthcare Conference being held from November 10-12, 2008
at the New York Palace Hotel in New York. The Company's
presentation is scheduled to begin at 4:30 p.m. Eastern Time on November
11, 2008. Representing PhotoMedex will be Jeffrey O'Donnell,
president and chief executive officer, and Dennis McGrath, chief
...
MONTGOMERYVILLE, Pa., Oct 31, 2008 (BUSINESS WIRE) -- PhotoMedex, Inc. (NASDAQ: PHMD) has been named to Deloitte's
prestigious Fast 50 Program for Greater Philadelphia, a ranking of the
50 fastest growing technology, media, telecommunications and life
sciences companies in the area by Deloitte LLP, one of the leading
professional services organizations in the U.S. Rankings are based on
the percentage revenue growth over five years from 2003-2007.
Jeff O'D...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Oct. 30, 2008--PhotoMedex,
Inc. (NASDAQ: PHMD), a leader in the development of proprietary
excimer laser and fiber optic systems as well as other products for
dermatological applications, today reported financial results for the
three months ended September 30, 2008.
Financial highlights of the 2008 third quarter, after classifying
the Surgical Services business unit as discontinued operations for
prior periods, include:
-- XTRAC ...
MONTGOMERYVILLE, Pa., Oct. 23 /PRNewswire-FirstCall/ -- PhotoMedex, Inc.
(Nasdaq: PHMD) will hold a conference call to discuss the Company's third
quarter 2008 results on Thursday, October 30, 2008 at 4:30 p.m. Eastern Time.
The third quarter results will be announced on October 30th, prior to the
conference call.
To participate in the conference call, dial 866-575-6538 (and confirmation
code # 6490210) approximately 5 to 10 minutes prior to the scheduled start
time. If you ar...
CARLSBAD, Calif. (September 26, 2008) – Photo Therapeutics (PTL), a leader in the development of proprietary therapeutic LED technology for the physician dermatology market, announced today with PhotoMedex that CVS/pharmacy is launching PTL’s proprietary Omnilux™ LED-based technology at nearly 600 Healthy Skincare locations this fall and cvs.com.
CVS/pharmacy to carry the Omnilux New-U™
CVS/pharmacy will distribute Photo Therapeutics’ clinically-proven hand-held LED device for skin rejuve...
CARLSBAD, Calif.--(BUSINESS WIRE)--Sept. 19, 2008--Photo
Therapeutics (PTL), a leader in the development of proprietary
therapeutic LED technology for the physician dermatology market,
announced today with PhotoMedex, Inc. (NASDAQ: PHMD) that, thanks to
N.V. Perricone MD., Ltd., its Omnilux LED-based technology has made
its debut to the consumer market.
N.V. Perricone M.D. launches LIGHT Renewal(TM)
N.V. Perricone M.D. Cosmeceuticals(R) has introduced LIGHT
Renewal(TM) treatm...
Omnilux(TM) Broadens Offering to U.S. Dermatologists, Adds
Treatment Options for Acne, Ocular Wrinkles, Superficial Wounds,
Non-Melanoma Skin Cancers
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Sept. 12, 2008--PhotoMedex,
Inc. (NASDAQ:PHMD), a leader in the development of proprietary excimer
laser systems and science based skin care products, today announced a
broad extension of its therapeutic product offerings to U.S.
dermatologists in anticipation of it...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Aug. 11, 2008--PhotoMedex,
Inc. (Nasdaq:PHMD) announced today that Jeffrey O'Donnell, its
president and chief executive officer, and Dennis McGrath, its chief
financial officer and vice president of finance, will present at the
Fourth Annual Noble Financial Equity Conference on Tuesday, August 19,
2008 at 10:30 a.m. Pacific time. The conference will be held at the
Loews Lake Las Vegas Resort, Nevada from August 18-19, 2008.
A live webcast of ...
MONTGOMERYVILLE, Pa., Aug 04, 2008 (BUSINESS WIRE) -- PhotoMedex, Inc. (NASDAQ: PHMD), a leader in the development of
proprietary excimer laser and fiber optic systems as well as other
products for dermatological applications, today reported financial
results for the three months ended June 30, 2008 and the sale of its
Surgical Services business unit.
Financial highlights of the 2008 second quarter, after adjusting
prior periods for the discontinued operations of the Surgical Services
bus...
Announces $25 Million Securities Purchase Agreement with Perseus,
L.L.C.
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Aug. 4, 2008--PhotoMedex,
Inc. (Nasdaq:PHMD), a leader in the development of proprietary excimer
laser and fiber optic systems as well as other products for
dermatological applications, today announced the signing of a
definitive purchase agreement to acquire Photo Therapeutics Limited
for $13 million in cash at closing, and up to an additional $7 ...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--July 28, 2008--PhotoMedex,
Inc. (Nasdaq: PHMD) will hold a conference call to discuss the
Company's second quarter 2008 results on Monday, August 4, 2008 at
4:30 p.m. Eastern Time.
The second quarter results will be announced on August 4th, prior
to the conference call.
To participate in the conference call, dial 888-256-9154 (and
confirmation code # 9676495) approximately 5 to 10 minutes prior to
the scheduled start time. If you are...
Breakthrough Retinol Technology Refines Skin Without Irritation
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--June 2, 2008--PhotoMedex,
Inc. (Nasdaq:PHMD) announced that Procyte, a PhotoMedex company, today
is introducing NEOVA(R) Matrix AR. Created with patented retinol
technology, NEOVA(R) Matrix AR is a topical formula that safely and
effectively reduces the appearance of photodamage, fine lines,
wrinkles and acne without the irritation typically experienced with
other retinol-based, p...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--May 21, 2008--PhotoMedex,
Inc. (Nasdaq:PHMD) announced today that Jeffrey O'Donnell, its
president and chief executive officer, and Dennis McGrath, its chief
financial officer and vice president of finance, will present at the
12th Annual FBR Capital Markets Spring Investor Conference on
Wednesday, May 28, 2008, 3:50 p.m. ET. The conference will be held at
the Grand Hyatt New York in New York City on May 28th and 29th, 2008.
A live webcast ...
MONTGOMERYVILLE, Pa., May 15, 2008 (BUSINESS WIRE) -- PhotoMedex, Inc. (NASDAQ: PHMD) today announced that, due to
increased interest from viewers, its XTRAC(R) excimer laser segment,
which first aired on Wednesday, May 7th, on The Balancing Act, an
original, daily half-hour series for working women on LIFETIME
Television, will also air on Friday, May 16 in addition to its
originally scheduled air time of Monday, May 26th. The segment will
feature Dr. Stefan C. Weiss, MD, Medical Director ...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--May 13, 2008--PhotoMedex,
Inc. (NASDAQ:PHMD), a leader in the development of proprietary excimer
laser and fiber optic systems as well as techniques directed toward
dermatological applications, today announced that it has received U.S.
Food and Drug Administration 510k clearance to market the new, more
powerful, faster XTRAC(R) Velocity(TM) excimer laser system to treat
psoriasis, vitiligo, atopic dermatitis and leukoderma.
The XTRAC Velocity...
Decision Covers Treatment of Psoriasis and Vitiligo
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--May 13, 2008--PhotoMedex,
Inc. (NASDAQ:PHMD), a leader in the development of proprietary excimer
laser and fiber optic systems as well as techniques directed toward
dermatological applications, today announced that BlueCross BlueShield
of Massachusetts has adopted a medical policy effective May 5, 2008
approving payment for medically necessary treatment of psoriasis and
vitiligo using the Ph...
MONTGOMERYVILLE, Pa., May 06, 2008 (BUSINESS WIRE) -- PhotoMedex, Inc. (NASDAQ: PHMD), a leader in the development of
proprietary excimer laser and fiber optic systems as well as
techniques directed toward dermatological applications, today reported
financial results for the three months ended March 31, 2008. Financial
highlights of the 2008 first quarter include:
Revenues of $10.2 million, up 13% versus the prior year
XTRAC(R) recognized procedures up 15% over the prior year and
...
MONTGOMERYVILLE, Pa., May 05, 2008 (BUSINESS WIRE) -- PhotoMedex, Inc. (NASDAQ:PHMD) today announced that its XTRAC(R)
excimer laser will be the subject of a segment of The Balancing Act,
an original, daily, half-hour series for working women on The LIFETIME
Television at 7:00AM, 6:00AM CDT. The segment, which will air on
Wednesday, May 7, and Monday, May 26, will also feature Stefan C.
Weiss, MD FAAD, Medical Director of the Weiss Skin Institute in Boca
Raton, Florida, and Adjunct Clinica...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--May 1, 2008--PhotoMedex,
Inc. (Nasdaq: PHMD) announced today that it received notification from
The Nasdaq Stock Market ("Nasdaq") on April 25, 2008 that the Company
was not in compliance with the $1.00 minimum bid price requirement for
continued listing on Nasdaq's Global Market exchange under Nasdaq
Marketplace Rule 4450(a)(5). Such a notification letter is issued when
the bid price of a Nasdaq-listed company closes below a $1.00 per
share bid ...
MONTGOMERYVILLE, Pa., Apr 30, 2008 (BUSINESS WIRE) -- PhotoMedex, Inc. (Nasdaq:PHMD) will hold a conference call to
discuss the Company's first quarter 2008 results on Tuesday, May 6,
2008 at 4:30 p.m. Eastern Time.
The first quarter results will be announced on May 6th, prior to
the conference call.
To participate in the conference call, dial 866-214-7077 (and
confirmation code # 9121494) approximately 5 to 10 minutes prior to
the scheduled start time. If you are unable to participate,...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--April 22, 2008--PhotoMedex,
Inc. (Nasdaq:PHMD) announced today that Jeffrey O'Donnell, its
president and chief executive officer, will present at the Third
Annual CIT Health Care Conference on Tuesday, April 29, 2008, 11:00
a.m. ET. The conference will be held at the Waldorf-Astoria Hotel in
New York City on April 29, 2008.
About PhotoMedex
PhotoMedex provides contract medical procedures to hospitals,
surgi-centers and doctors' offices, ...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--April 14, 2008--PhotoMedex,
Inc. (Nasdaq: PHMD) announced today that Dennis McGrath, its chief
financial officer and vice president of finance, will present at the
LD MICRO Conference on Tuesday, April 29, 12:00 Noon PT. The
conference will be held at the Omni Los Angeles Hotel on April 29,
2008, in Los Angeles, California.
About PhotoMedex
PhotoMedex provides contract medical procedures to hospitals,
surgi-centers and doctors' offices, ...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--March 11, 2008--PhotoMedex,
Inc. (Nasdaq: PHMD) announced that it received notification from The
Nasdaq Stock Market ("Nasdaq") on March 10, 2008 saying the Company
regained compliance with the $1.00 minimum bid price requirement for
continued listing on Nasdaq's Global Market exchange under Marketplace
Rule 4450(a)(5). In the letter, Nasdaq advised the Company that this
matter is now closed.
The Company had until May 19, 2008 to regain compl...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--March 5, 2008--PhotoMedex,
Inc. (Nasdaq: PHMD) announced today that Jeffrey O'Donnell, its
president and chief executive officer, and Dennis McGrath, its chief
financial officer and vice president of finance, will present at the
Cowen and Company 28th Annual Health Care Conference on Monday, March
17, 3:15 p.m. ET. The conference will be held at the Boston Marriott
Copley Place Hotel in Boston from March 17 - March 20, 2008.
A live webcast of...
Study Reveals 75% To 90% Improvement in PASI Score for Appropriate
Patients
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--March 4, 2008--PhotoMedex,
Inc. (NASDAQ: PHMD) a leader in the development of proprietary excimer
laser and fiber optic systems as well as techniques directed toward
dermatological applications, today announced the results of a pilot
study indicating that the use of the company's XTRAC Excimer Laser is
effective in treating patients wi...
Increase in Fourth Quarter Revenues of 28% Sequentially Results in
Positive 2007 EBITDA
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Feb. 27, 2008--PhotoMedex,
Inc. (NASDAQ: PHMD) today reported financial results for the three and
12 months ended December 31, 2007. Financial highlights of the 2007
fourth quarter and year include:
EBITDA for the year up 182% to $1.0 million as revenues
increased 17% to $38.7 million;
XTRAC 2007 domestic revenues of $9...
MONTGOMERYVILLE, Pa., Feb 20, 2008 (BUSINESS WIRE) -- PhotoMedex, Inc. (Nasdaq:PHMD) will hold a conference call to
discuss the Company's fourth quarter 2007 results on Wednesday,
February 27, 2008 at 4:30 p.m. Eastern Time.
The fourth quarter results will be announced on February 27th,
prior to the conference call.
To participate in the conference call, dial 800-270-6751 (and
confirmation code # 4120337) approximately 5 to 10 minutes prior to
the scheduled start time. If you are unable...
Company Plans to Expand Sales Staff
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Jan. 30, 2008--PhotoMedex
(Nasdaq: PHMD) today announced that Blue Shield of California has
adopted a medical policy effective January 11, 2008 approving payment
for medically necessary treatment of mild to moderate psoriasis using
the PhotoMedex XTRAC(R) laser system. Blue Shield of California is one
of the largest insurers in California, covering more than three
million lives.
"This positive coverage...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Jan. 7, 2008--PhotoMedex
(Nasdaq:PHMD) announced that Procyte, a PhotoMedex company, is
introducing their first advanced cosmetic peel designed for sensitive
skin or first time users. Procyte has been widely respected for more
than 20 years of R&D behind its revolutionary GHK and AHK Copper
Peptide technology. The Facial Peel Kit is derived from 30% lactic
acid (an alpha hydroxy acid found in milk) with a pH level of 2.0,
making it an aggressive,...
